Evidence map›Paper›PMID 27149219›Full record

ArticleNature medicine2016

Facilitating a culture of responsible and effective sharing of cancer genome data.

Lillian L Siu, Mark Lawler, David Haussler, Bartha Maria Knoppers, Jeremy Lewin, Daniel J Vis, Rachel G Liao, Fabrice Andre, Ian Banks, J Carl Barrett and 13 more

Abstract read
In one paragraph

Article in Nature medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. The omics discovery REST interface.Nucleic acids research · 2020
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Lillian L SiuPrincess Margaret Cancer Centre, University of Toronto, Toronto, Canada.
Mark LawlerCentre for Cancer Research and Cell Biology, Queen's University, Belfast, UK.
David HausslerUC Santa Cruz Genomics Institute, University of California, Santa Cruz, California, USA.
Bartha Maria KnoppersCentre of Genomics and Policy, McGill University, Montreal, Canada.
Jeremy LewinPrincess Margaret Cancer Centre, University of Toronto, Toronto, Canada.
Daniel J VisThe Netherlands Cancer Institute, Amsterdam, the Netherlands.
Rachel G LiaoThe Global Alliance for Genomics and Health, Toronto, Canada.
Fabrice AndreGustave Roussy and Université Paris Sud, Villejuif, France.
Ian BanksPatient's Advocacy Committee, European Cancer Organization, Brussels, Belgium.
J Carl BarrettTranslational Sciences, Oncology iMED, AstraZeneca, Waltham, Massachusetts, USA.
Carlos CaldasDepartment of Oncology, University of Cambridge, Cambridge, UK.
Anamaria Aranha CamargoHospital Sírio-Libanês, São Paulo, Brazil.
Rebecca C FitzgeraldDepartment of Oncology, University of Cambridge, Cambridge, UK.
Mao MaoYonsei Cancer Research Institute, Yonsei University College of Medicine, Seoul, Korea.
John E MattisonKaiser Permanente, Pasadena, California, USA.
William PaoRoche Innovation Center Basel, Pharma Research and Early Development, Roche, Basel, Switzerland.
William R SellersNovartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA.ORCID 0000-0003-2604-2498
Patrick SullivanAdvocacy for Canadian Children Oncology Network, Vancouver, Canada.
Bin Tean TehNational Cancer Centre Singapore, Singapore.
Robyn L WardUniversity of Queensland, St. Lucia, Australia.
Jean Claude ZenKlusenThe Cancer Genome Atlas, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Charles L SawyersMemorial Sloan Kettering Cancer Center, New York, New York, USA.
Emile E VoestThe Netherlands Cancer Institute, Amsterdam, the Netherlands.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Training SubprojectU54HG007990 · NHGRI · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI HAUSSLER, DAVID H, PATTERSON, DAVID · 2014 to 2018
$14.8M
Cancer Research UK 16942Cancer Research UK 22720Cancer Research UK 9675Howard Hughes Medical InstituteNCI NIH HHS P30 CA008748NHGRI NIH HHS U54 HG007990
6 · The paper itself

Abstract

Rapid and affordable tumor molecular profiling has led to an explosion of clinical and genomic data poised to enhance the diagnosis, prognostication and treatment of cancer. A critical point has now been reached at which the analysis and storage of annotated clinical and genomic information in unconnected silos will stall the advancement of precision cancer care. Information systems must be harmonized to overcome the multiple technical and logistical barriers to data sharing. Against this backdrop, the Global Alliance for Genomic Health (GA4GH) was established in 2013 to create a common framework that enables responsible, voluntary and secure sharing of clinical and genomic data. This Perspective from the GA4GH Clinical Working Group Cancer Task Team highlights the data-aggregation challenges faced by the field, suggests potential collaborative solutions and describes how GA4GH can catalyze a harmonized data-sharing culture.

Indexed as

GenomeInformation DisseminationComputational BiologyCultureDatabases, GeneticHumansNeoplasms

Identifiers

PMID27149219
PMCPMC4995884

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.